AMICUS THERAPEUTICS INC 4
4 · AMICUS THERAPEUTICS INC · Filed May 12, 2015
Insider Transaction Report
Form 4
Valenzano Ken
VP, Pharmacology & Biology
Transactions
- Tax Payment
Common stock
2015-05-08$10.80/sh−9,313$100,580→ 15,687 total - Sale
Common stock
2015-05-11$10.84/sh−5,000$54,200→ 10,687 total - Sale
Common stock
2015-05-11$10.85/sh−8,000$86,810→ 2,687 total - Exercise/Conversion
Common stock
2015-05-08+25,000→ 25,000 total - Exercise/Conversion
Restricted stock units
2015-05-08−25,000→ 25,000 total→ Common Stock (25,000 underlying)
Footnotes (6)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The sale of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2014.
- [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.7262 to $10.95. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The sale of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
- [F5]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.73 to $10.98. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F6]On April 10, 2014, the reporting person was granted 50,000 restricted stock units, vesting in equal installments of 25,000 restricted stock units on May 10, 2015 and 25,000 restricted stock units on December 3, 2015.